Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction

Aldo Moggio1, Heribert Schunkert1,2, Thorsten Kessler1,2

  • 1Department of Cardiology, German Heart Center Munich, Technical University Munich, 80636 Munich, Germany.

Insights

Myocardial infarction triggers inflammation, depleting blood leukocytes. This review examines the "leukocyte supply chain" from bone marrow to heart post-infarction.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Hematology

Background:

  • Myocardial infarction (MI) causes heart tissue damage due to insufficient blood flow.
  • This ischemic injury initiates a significant inflammatory response, recruiting large numbers of leukocytes.
  • The depletion of circulating leukocytes necessitates rapid replenishment.

Purpose of the Study:

  • To review the "leukocyte supply chain" in the context of myocardial infarction.
  • To evaluate myeloid cell compartments (bone marrow, spleen, blood, heart) in steady state and post-MI.
  • To highlight the role of extracellular factors and chemokines in myeloid cell regulation during MI inflammation.

Main Methods:

  • Review of existing literature on leukocyte kinetics and inflammatory responses post-MI.
  • Analysis of myeloid cell populations in different anatomical compartments.
  • Examination of signaling molecules regulating myeloid cell behavior.

Main Results:

  • MI leads to rapid depletion of blood leukocytes, requiring mobilization from supply organs.
  • Myeloid cell generation, release, and trafficking are dynamically regulated after cardiac injury.
  • Specific chemokines and danger signals orchestrate the inflammatory cell response.

Conclusions:

  • Understanding the leukocyte supply chain is crucial for managing MI-induced inflammation.
  • Targeting myeloid cell kinetics may offer novel therapeutic strategies for heart attack recovery.
  • The interplay between local injury and systemic myeloid cell responses is complex and vital.